Koninklijke Philips N.V.
Koninklijke Philips N.V. (PHG) is a global health technology company focused on diagnostic imaging, image-guided therapy, patient monitoring, and health informatics, with minimal direct U.S. political exposure evidenced by $0 federal contracts, $0 lobbying spend, and no congressional trading in the last 12 months.
BusinessWhat PHG does
Philips operates in the health technology sector, generating revenue through the sale of medical devices such as MRI and CT systems, ultrasound equipment, patient monitoring solutions, and enterprise informatics software. The company also provides services including maintenance, consulting, and digital health solutions. Its business model combines product sales with recurring service and software revenue streams.
12 months past · 3 months futurePHG activity timeline
Lifetime Government AwardsPHG federal contracts
PHG doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding PHG
Congressional TradesWho in Congress is trading PHG
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting PHGLive legislation impacting this stock
Political ProfileWhere PHG sits in Washington
[object Object]
STRUCTURAL: High regulatory density (85) due to healthcare sector exposure per bill_impacts array with 8 bills. EVIDENTIARY: No federal contracts (get_government_precedent.federal_contracts_summary null), $0 lobbying (get_political_influence.lobbying.total_income 0), no corporate insider buys in 180 days (get_corporate_insider_signal.total_buys 0), and no congressional traders (Top congressional traders array empty). Net: Minimal direct political engagement but subject to sector-wide regulatory risk.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
High regulatory density in healthcare sector impacting medical device approvals and reimbursementFDA, CMS"Recent bill_impacts array shows 8 healthcare bills with low but non-zero impact_ratios, indicating legislative scrutiny"
Regulatory opportunities
-
Potential inclusion in federal procurement or healthcare IT incentives via legislationHHS, VA"Recent bill_impacts array shows multiple healthcare bills with estimated revenue impacts, though small"
Live signals + predictions for PHG — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades PHG
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord